Mirtazapine

Basic mirtazapine information

• INN (international nonproprietary name): mirtazapine
• Brand names available in the United Kingdom: Zispin SolTab; generic mirtazapine
• ATC code: N06AX11
• Forms and dosages: film-coated tablets and orodispersible tablets (15 mg, 30 mg, 45 mg); oral solution 15 mg/mL
• Manufacturers in the United Kingdom: Organon (Zispin SolTab); generic mirtazapine from several manufacturers
• Registration status in the United Kingdom: licensed by the MHRA; prescription only
• OTC / Rx classification: Prescription-only medicine (POM)

Everyday use and best practices

When it comes to mirtazapine, timing and food intake can influence how well it suits you.

Morning vs evening dosing

Mirtazapine is usually taken as a single dose at bedtime, because its sedative effect can help with sleep problems. Some people feel groggy the next morning if they take it too late.

• Individual needs: consult your prescriber to tailor the dosing schedule to your needs.
• Optimal effects: taking mirtazapine at a consistent time daily helps to maintain steady levels of the medicine.

Taking with or without meals

Mirtazapine is absorbed well regardless of food, so it can be taken with or without meals. Taking it with food may help reduce stomach discomfort. Take it at a time that fits comfortably within your regular routine.

Speak to your doctor or pharmacist if you have questions about safe and effective use.

Safety priorities

When considering the use of mirtazapine, safety should always be at the forefront. This medication, primarily used to treat major depressive disorder, can have several side effects that require attention. Common side effects include sedation, increased appetite and weight gain, making it crucial for users to carefully assess their health circumstances before starting this medication. Those with pre-existing conditions, particularly involving the liver or kidneys, should approach mirtazapine use with caution to avoid any adverse effects. Furthermore, following the prescribing doctor’s guidance on dosage and monitoring for side effects can ensure safer use.

Who should avoid it

It's essential to be aware of the contraindications surrounding mirtazapine. High-risk patient groups include:

• Individuals with known hypersensitivity to mirtazapine or its components.
• Patients currently using monoamine oxidase inhibitors (MAOIs) or those who have discontinued them less than 14 days prior.
• Those with a history of mania, seizures, or cardiovascular issues.
• The elderly, who may be more prone to sedation and potential falls.

Caution and monitoring are advised in patients with severe liver or renal impairment. It's also crucial to weigh the risks of sedation against the benefits of treatment, especially for those in safety-sensitive roles.

Activities to limit (driving, work safety)

The sedative properties of mirtazapine can significantly impact daily activities. Individuals are generally warned against engaging in activities requiring mental alertness, such as driving or operating heavy machinery. Mirtazapine commonly causes drowsiness, and this may heighten the risk of accidents.

Recommendations include:

• Waiting until the medication effects are fully understood before driving after taking mirtazapine.
• Consulting with a healthcare provider about when it is safe to resume such activities.

By prioritising safety and adhering to these guidelines, individuals can mitigate risks while receiving the therapeutic benefits that mirtazapine offers.

General regimen (NHS guidance)

The management of major depressive disorder often utilises mirtazapine as a key medication, with standard dosages typically ranging from 15 to 45 mg daily. This regimen, while effective for most patients, highlights the necessity for a tailored approach based on individual patient needs.

Adherence to prescribing guidelines is critical, as following these protocols can significantly enhance the therapeutic effects of the medication while minimising potential risks. It's important for patients to engage openly with their healthcare providers about their treatment journey, discussing any side effects or concerns that may arise during treatment.

Special cases (elderly, comorbidities)

In instances involving the elderly or patients with comorbidities such as liver or renal impairment, careful adjustments to mirtazapine dosing may be required. Starting doses of 7.5 to 15 mg are often recommended to mitigate the risk of adverse effects, particularly sedation and orthostatic hypotension.

Medical supervision becomes even more essential in these cases as the complexities of treating patients with multiple health issues can lead to varied responses to the medication. Regular monitoring allows for safe titration of the dosage, ensuring the best possible outcomes while managing any potential side effects.